Japan 2012 Drug Sales Ended Nearly Flat On Price Revision, Generic Promotion: IMS Japan
This article was originally published in PharmAsia News
Executive Summary
Japan’s prescription drug market achieved sales of ¥9.56 trillion ($93 billion), a 0.3% increase from the previous year, according to a survey by IMS.